Resilience and Relapse Risk in Emirate Adult Patients with Substance Use Disorder: a National Cross-sectional Study from the United Arab Emirates

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2024 Oct 9

PMID 39381607

Authors

Ibraheem Mhaidat

Nabeel Al-Yateem

Samya Al-Mamari

Fatima Al-Suwaidi

Affiliations

Soon will be listed here.

Abstract

Introduction: United Arab Emirates is among the countries affected by substance use disorders (SUDs), which have economic and social impacts. Relapse after successful rehabilitation is a major issue in the treatment of SUD. Several factors increase the risk of relapse in patients with SUD, such as craving and negative social experiences. Resilience could empower patients struggling with SUD. This study aims to explore levels of resilience and relapse risk in adult Emirati patients diagnosed with SUD, and also the possible correlation between the two variables.

Methods: Two hundred eighty-six Emirati adult patients with SUD completed a self-administered questionnaire for demographics, resilience (Connor and Davidson Resilience Scale), and relapse risk (Stimulant Relapse Risk Scale). Descriptive statistics (frequency, percentage, mean, SD, etc.) were used to describe study participants and variables. Inferential statistics were used to analyze the relationships, associations, and correlations between resilience and relapse risk, the main variables, and the participants demographics.

Result: Participants' mean total score for resilience was 72.92 out of a maximum possible score of 100 (SD = 16.99), while their mean total score for relapse risk was 59.07 out of a maximum possible score of 105 (SD = 12.23). Furthermore, examining the correlation between the resilience subscales and the relapse risk subscales revealed similar significant, negative, low-to-moderate correlations between all the subscales (r = -0.486).

Discussion: Protective and risk factors to enhance resilience and reduce relapse risk in patients with SUD were discussed.

References

Yamashita A, Yoshioka S, Yajima Y . Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study. Subst Abuse Treat Prev Policy. 2021; 16(1):40. PMC: 8097930. DOI: 10.1186/s13011-021-00377-8. View

Enkema M, Bowen S . Mindfulness practice moderates the relationship between craving and substance use in a clinical sample. Drug Alcohol Depend. 2017; 179:1-7. DOI: 10.1016/j.drugalcdep.2017.05.036. View

Knapp K, Brick T, Bunce S, Deneke E, Cleveland H . Daily meaningfulness among patients with opioid use disorder: Examining the role of social experiences during residential treatment and links with post-treatment relapse. Addict Behav. 2021; 119:106914. PMC: 8115945. DOI: 10.1016/j.addbeh.2021.106914. View

Fredrickson B . The role of positive emotions in positive psychology. The broaden-and-build theory of positive emotions. Am Psychol. 2001; 56(3):218-26. PMC: 3122271. DOI: 10.1037//0003-066x.56.3.218. View

Dyer J, McGuinness T . Resilience: analysis of the concept. Arch Psychiatr Nurs. 1996; 10(5):276-82. DOI: 10.1016/s0883-9417(96)80036-7. View

Masten A . Ordinary magic. Resilience processes in development. Am Psychol. 2001; 56(3):227-38. DOI: 10.1037//0003-066x.56.3.227. View

Ogai Y, Haraguchi A, Kondo A, Ishibashi Y, Umeno M, Kikumoto H . Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan. Drug Alcohol Depend. 2006; 88(2-3):174-81. DOI: 10.1016/j.drugalcdep.2006.10.005. View

Hagen E, Erga A, Hagen K, Nesvag S, McKay J, Lundervold A . One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder. J Subst Abuse Treat. 2017; 76:81-87. DOI: 10.1016/j.jsat.2017.01.016. View

Dutra L, Stathopoulou G, Basden S, Leyro T, Powers M, Otto M . A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008; 165(2):179-87. DOI: 10.1176/appi.ajp.2007.06111851. View

10.

AlMarri T, Oei T . Alcohol and substance use in the Arabian Gulf region: a review. Int J Psychol. 2011; 44(3):222-33. DOI: 10.1080/00207590801888752. View

11.

Manca F, Lewsey J . Hospital discharge location and socioeconomic deprivation as risk factors for alcohol dependence relapses: A cohort study. Drug Alcohol Depend. 2021; 229(Pt A):109148. DOI: 10.1016/j.drugalcdep.2021.109148. View

12.

Padula C, Hansen A, Hughes R, McNerney M . Dimensions of Craving Interact with Genotype to Predict Relapse in Individuals with Alcohol Use Disorder Six Months after Treatment. Brain Sci. 2021; 11(1). PMC: 7825287. DOI: 10.3390/brainsci11010062. View

13.

Haller M, Handley E, Chassin L, Bountress K . Developmental cascades: linking adolescent substance use, affiliation with substance use promoting peers, and academic achievement to adult substance use disorders. Dev Psychopathol. 2010; 22(4):899-916. PMC: 2971659. DOI: 10.1017/S0954579410000532. View

14.

Goodman D, Saunders E, Wolff K . In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders. BMC Pregnancy Childbirth. 2020; 20(1):178. PMC: 7081623. DOI: 10.1186/s12884-020-02872-5. View

15.

Xia Y, Gong Y, Wang H, Li S, Mao F . Family Function Impacts Relapse Tendency in Substance Use Disorder: Mediated Through Self-Esteem and Resilience. Front Psychiatry. 2022; 13:815118. PMC: 8882822. DOI: 10.3389/fpsyt.2022.815118. View

16.

Leppin A, Bora P, Tilburt J, Gionfriddo M, Zeballos-Palacios C, Dulohery M . The efficacy of resiliency training programs: a systematic review and meta-analysis of randomized trials. PLoS One. 2014; 9(10):e111420. PMC: 4210242. DOI: 10.1371/journal.pone.0111420. View

17.

Nguyen L, Durazzo T, Dwyer C, Rauch A, Humphreys K, Williams L . Predicting relapse after alcohol use disorder treatment in a high-risk cohort: The roles of anhedonia and smoking. J Psychiatr Res. 2020; 126:1-7. PMC: 8476113. DOI: 10.1016/j.jpsychires.2020.04.003. View

18.

Hunter S, Watkins K, Hepner K, Paddock S, Ewing B, Osilla K . Treating depression and substance use: a randomized controlled trial. J Subst Abuse Treat. 2012; 43(2):137-51. PMC: 3345298. DOI: 10.1016/j.jsat.2011.12.004. View

19.

Riehman K, Iguchi M, Anglin M . Depressive symptoms among amphetamine and cocaine users before and after substance abuse treatment. Psychol Addict Behav. 2002; 16(4):333-7. DOI: 10.1037//0893-164x.16.4.333. View

20.

Daigre C, Rodriguez L, Roncero C, Palma-Alvarez R, Perea-Ortueta M, Sorribes-Puertas M . Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit. Addict Behav. 2021; 117:106832. DOI: 10.1016/j.addbeh.2021.106832. View